Surrozen (SRZN) News Today $10.96 -0.44 (-3.82%) As of 03/28/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Surrozen, Inc. (NASDAQ:SRZN) Major Shareholder Group Gp Lp Column III Purchases 1,034,482 SharesMarch 29 at 5:54 AM | insidertrades.comSurrozen to focus Wnt expertise, technologies on ophthalmology programsMarch 27 at 10:42 AM | markets.businessinsider.comSurrozen to discontinue development of SZN-043 in alcohol associated hepatitisMarch 26, 2025 | markets.businessinsider.comSurrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye DiseasesMarch 24, 2025 | globenewswire.comReviewing Surrozen (NASDAQ:SRZN) and Acumen Pharmaceuticals (NASDAQ:ABOS)March 22, 2025 | americanbankingnews.comSurrozen (NASDAQ:SRZN) Stock Quotes, Forecast and News SummaryJanuary 30, 2025 | benzinga.comHC Wainwright & Co. Initiates Coverage of Surrozen (SRZN) with Buy RecommendationJanuary 30, 2025 | msn.comH.C. Wainwright sets $32 target on Surrozen stock with Buy ratingJanuary 30, 2025 | msn.comSurrozen initiated with a Buy at H.C. WainwrightJanuary 30, 2025 | markets.businessinsider.comHere's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn SituationJanuary 22, 2025 | uk.finance.yahoo.comSurrozen, Inc. (NASDAQ:SRZN) VP Sells $14,642.91 in StockJanuary 7, 2025 | insidertrades.comGuggenheim upgrades Surrozen to Buy after ‘encouraging’ SZN-043 dataJanuary 4, 2025 | markets.businessinsider.comSurrozen upgraded to Buy from Neutral at GuggenheimJanuary 4, 2025 | markets.businessinsider.comGuggenheim Upgrades Surrozen (SRZN)January 4, 2025 | msn.comSurrozen, Inc.: Q3 2024 Earnings OverviewNovember 25, 2024 | tipranks.comSurrozen to Present at Upcoming Healthcare Investor ConferencesNovember 6, 2024 | globenewswire.comSurrozen Provides Third Quarter 2024 Financial Results and Business UpdateNovember 6, 2024 | globenewswire.comSurrozen, TCGFB announce strategic research collaborationNovember 5, 2024 | markets.businessinsider.comSurrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary FibrosisNovember 4, 2024 | globenewswire.comSurrozen Earns $10 Million Milestone Payment in Retinal Diseases CollaborationSeptember 24, 2024 | globenewswire.comSurrozen, Inc.: Surrozen Provides Second Quarter 2024 Financial Results and Business UpdateAugust 19, 2024 | finanznachrichten.deCompanies Like Surrozen (NASDAQ:SRZN) Could Be Quite RiskyAugust 15, 2024 | finance.yahoo.comSRZN Stock Earnings: Surrozen Misses EPS for Q2 2024August 13, 2024 | investorplace.comSurrozen Provides Second Quarter 2024 Financial Results and Business UpdateAugust 12, 2024 | globenewswire.comSurrozen Publishes Study in ‘eLife' Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt SignalingJune 12, 2024 | globenewswire.comSurrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in MilanJune 10, 2024 | globenewswire.comSurrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated HepatitisJune 4, 2024 | globenewswire.comSurrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual MeetingMay 9, 2024 | globenewswire.comSRZN Stock Earnings: Surrozen Beats EPS for Q1 2024May 9, 2024 | investorplace.comSurrozen Provides First Quarter 2024 Financial Results and Business UpdateMay 8, 2024 | globenewswire.comSurrozen files to sell 1.09M shares of common stock for holdersApril 18, 2024 | msn.comSurrozen (SRZN) Price Target Decreased by 40.00% to 20.66April 18, 2024 | msn.comSurrozen director Tim Kutzkey acquires $3m in company stockApril 10, 2024 | uk.investing.comTrading was temporarily halted for "SRZN" at 01:04 PM with a stated reason of "LULD pause."April 9, 2024 | marketbeat.comInsider Buying: Surrozen, Inc. (NASDAQ:SRZN) Director Buys 193,548 Shares of StockApril 9, 2024 | insidertrades.comSurrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary FibrosisApril 3, 2024 | globenewswire.comU.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.60%April 1, 2024 | msn.comWhy Is Regenerative Medicine-Focused Surrozen Stock Trading Lower On Monday?April 1, 2024 | msn.comSurrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq RulesApril 1, 2024 | globenewswire.comSurrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043April 1, 2024 | globenewswire.comSurrozen Promotes Charles Williams to COO with CFO RoleFebruary 8, 2024 | msn.comSurrozen, Inc.: Surrozen Provides Corporate Update on Clinical ProgramsJanuary 18, 2024 | finanznachrichten.deSurrozen, Inc. (SRZNW) Stock Price, News, Quote & History - Yahoo FinanceJanuary 18, 2024 | ca.finance.yahoo.comSurrozen Provides Corporate Update on Clinical ProgramsJanuary 18, 2024 | finance.yahoo.comWe're Keeping An Eye On Surrozen's (NASDAQ:SRZN) Cash Burn RateJanuary 3, 2024 | finance.yahoo.comTrading was temporarily halted for "SRZN" at 07:12 PM with a stated reason of "News pending."December 14, 2023 | marketbeat.com3 Biotech Stocks to Watch in NovemberNovember 10, 2023 | stocknews.comSurrozen GAAP EPS of -$0.34 misses by $0.03November 9, 2023 | msn.comSurrozen Provides Third Quarter 2023 Financial ResultsNovember 8, 2023 | finance.yahoo.comSurrozen Inc Ordinary Shares SRZNNovember 4, 2023 | morningstar.com Remove Ads Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address SRZN Media Mentions By Week SRZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRZN News Sentiment▼1.110.81▲Average Medical News Sentiment SRZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRZN Articles This Week▼60▲SRZN Articles Average Week Remove Ads Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IVA News Today HURA News Today GLSI News Today LRMR News Today CGEN News Today ZNTL News Today ACTU News Today OGI News Today SAVA News Today DERM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRZN) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
